Prior to joining RIVM, Dr. Ainslie was a postdoctoral researcher at the MRC Centre for Global Infectious Disease Analysis at Imperial College London. She specifically developed individual-based mathematical models of susceptibility, to determine how repeated exposures to pathogens (e.g., influenza) or interventions (e.g., vaccines) influence an individual’s susceptibility to subsequent infections. Dr. Ainslie was also a member of the Imperial COVID-19 Response Team and part of the Real-time Assessment of Community Transmission (REACT) study analytical team.
Dr. Ainslie obtained a PhD Doctor of Philosophy (Doctor of Philosophy) in biostatistics from Emory University. Her doctoral research focused on developing stochastic, agent-based models of infectious diseases and statistical methods to evaluate vaccine effectiveness from observational studies.